Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Anti-PDGF receptor alpha antibody shows promising results in rodent glioblastoma model

Oct. 11, 2004

Anti-VEGFR antibody reduces lymphangiogenesis in vivo

Oct. 11, 2004

Glycotope-specific antibody shows cytotoxic activity against gastrointestinal tumor in vivo

Oct. 11, 2004

Preliminary phase II data on the antitumor efficacy of TG-4010 in NSCLC

Oct. 11, 2004

Antibody targeting melanoma glycoprotein-proteoglycan complex shows anticancer efficacy in vivo

Oct. 11, 2004

Multiferon increases overall survival in melanoma study

Oct. 8, 2004

Pfizer claims anti-c-Met antibodies and their use in cancer therapy

Oct. 8, 2004

Fast track designation for MDX-010 in metastatic melanoma

Oct. 7, 2004

Stellar Biotechnologies awarded NCI grant for KLH development

Oct. 7, 2004

Triton BioSystems licenses ING-1 antibody from Xoma

Oct. 7, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...